You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 4, April 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Amyotrophic Lateral Sclerosis
 •Dementias
 •Motor Neuron Disease
 •Neuromuscular diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Frontotemporal Lobar Degeneration With Motor Neuron Disease

A Clinical and Pathological Spectrum

Arch Neurol. 2006;63:489-490.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Frontotemporal lobar degeneration (FTLD) is second only to Alzheimer disease as a cause of progressive cognitive impairment. The diagnostic category encompasses a phenotypic and pathologically heterogeneous group of disorders that begs to be split into distinct, clinically recognizable units. The clinical phenotype involves a variable spectrum of impairments in behavior and language, psychiatric symptoms, and motor signs in pyramidal and extrapyramidal systems.1-3

Based on the clinical features, patients are grouped into behavioral (frontotemporal dementia) and language (primary progressive aphasia and semantic dementia) subtypes or into specific clinical syndromes such as frontotemporal dementia with motor neuron disease (FTD-MND), corticobasal degeneration, and progressive supranuclear palsy. The pathologic spectrum associated with FTLD is equally heterogeneous, with the initial division based on immunohistochemical evidence for the presence of cytoplasmic aggregation of the microtubule associated protein tau.1-2 Those with tau inclusions (ie, tauopathies) are further categorized based on distinctive histopathologic and biochemical findings into Pick . . . [Full Text of this Article]

AUTHOR INFORMATION

Christopher M. Clark, MD; Mark S. Forman, MD, PhD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Clinically Undetected Motor Neuron Disease in Pathologically Proven Frontotemporal Lobar Degeneration With Motor Neuron Disease
Keith A. Josephs, Joseph E. Parisi, David S. Knopman, Bradley F. Boeve, Ronald C. Petersen, and Dennis W. Dickson
Arch Neurol. 2006;63(4):506-512.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.